Ospedale Maggiore Azienda Sanitaria Universitaria Trieste Ematologia

Academic/Hospital

Also known as: Ospedale Maggiore Azienda Sanitaria Universitaria Trieste Ematologia | S.C. Ematologia, Trieste - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Apr 30, 2019

Last known activity

Mar 1, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 2 trials)

Phase 2 (4 own, 0 via acquisition)

carfilzomib
lenalidomide
daratumumab
dexamethasone

Indications

Studied for

Immunoblastic Lymphadenopathy
Lymphoma
Lymphoma, Mantle-Cell
Lymphoma, T-Cell

Recent trials (2)

NCT04251065Overall official - principal investigatorPhase 2Mar 1, 2020
NCT03891355Overall official - principal investigatorPhase 2Apr 30, 2019

Details

Last known activity: Mar 1, 2020